Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $8.6500 (8.4%) ($7.7700 - $8.7800) on Sun. Jun. 30, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.86% (three month average) | RSI | 68 | Latest Price | $8.6500(8.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 3.9% a day on average for past five trading days. | Weekly Trend | TGTX advances 2.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting TGTX price | TGTX will decline at least -1.93% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.93% (StdDev 3.86%) | Hourly BBV | 0 () | Intraday Trend | 9.2% | | | |
|
5 Day Moving Average | $7.47(15.8%) | 10 Day Moving Average | $7.5(15.33%) | 20 Day Moving Average | $7.28(18.82%) | To recent high | 0% | To recent low | 38% | Market Cap | $N/A | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |